Paula Maria Wilhelmina Van Helden

Title: Paula Maria Wilhelmina Van Helden: Innovator in Antibody Production

Introduction

Paula Maria Wilhelmina Van Helden is a prominent inventor based in Amsterdam Zuidoost, Netherlands. She has made significant contributions to the field of biotherapeutics, particularly in the area of antibody production. With a total of four patents to her name, her work has the potential to impact therapeutic applications significantly.

Latest Patents

One of her latest patents is focused on ex vivo antibody production. This invention provides means and methods for producing improved ex vivo B cell cultures with a short doubling time. Another notable patent is for a therapeutic anti-CD9 antibody, which presents novel binding compounds and therapeutic applications thereof. These innovations showcase her commitment to advancing medical science.

Career Highlights

Throughout her career, Paula has worked with several companies, including Kling Biotherapeutics B.V. and Aimm Therapeutics B.V. Her experience in these organizations has allowed her to develop and refine her innovative ideas, contributing to the advancement of biotherapeutic technologies.

Collaborations

Paula has collaborated with notable professionals in her field, including Hergen Spits and Wouter Pos. These partnerships have likely enriched her research and development efforts, fostering a collaborative environment for innovation.

Conclusion

Paula Maria Wilhelmina Van Helden is a trailblazer in the field of antibody production, with a strong portfolio of patents and a collaborative spirit. Her work continues to pave the way for advancements in therapeutic applications.